Back to search

Article

Morphological profiling by Cell Painting in human neural progenitor cells classifies hit compounds in a pilot drug screen for Alzheimer’s disease

2023-01-18

Abstract excerpt

1 Alzheimer’s disease (AD) accounts for 60-70% of dementia cases. Current treatments are inadequate and there is a need to develop new approaches to AD drug discovery. We chose to develop a cell phenotype-based drug screen centred on the AD-risk gene, SORL1 , which encodes the protein SORLA. Increased AD risk has been repeatedly linked to variants in SORL1 , particularly those that confer loss of, or decreased,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
69d50854-e37b-55f7-ab62-0fc6051338fa
DOI
10.1101/2023.01.16.523559
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Morphological profiling by Cell Painting in human neural progenitor cells classifies hit compounds in a pilot drug screen for Alzheimer’s diseaseDOI 10.1101/2023.01.16.523559
Select a neighboring publication to make it the new centre.